Add Company
Join Now

SciVac Limited Revenue and Competitors

License our Company Data API

Rehovot, ISR

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • SciVac Limited's estimated annual revenue is currently $9.1M per year.(i)
  • SciVac Limited's estimated revenue per employee is $155,000

Employee Data

  • SciVac Limited has 59 Employees.(i)
  • SciVac Limited grew their employee count by -23% last year.

SciVac Limited's People

NameTitleEmail/Phone
1
President & CEOReveal Email/Phone
2
Chief Scientific OfficerReveal Email/Phone
3
Chief Financial Officer & Head Corporate DevelopmentReveal Email/Phone
4
VP Preclinical Translational DevelopmentReveal Email/Phone
5
VP - Market Access & Contract OperationsReveal Email/Phone
6
SVP Business DevelopmentReveal Email/Phone
7
SVP FinanceReveal Email/Phone
8
SVP, Market Access and CommercialReveal Email/Phone
9
SVP, Business DevelopmentReveal Email/Phone
10
VP For Immunization Policy, Government Affairs, and AdvocacyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$9.1M59-23%N/AN/A
#2
$22.3M144-3%N/AN/A
#3
$9.1M59-23%N/AN/A
#4
N/A5534%N/AN/A
Add Company

What Is SciVac Limited?

SciVac Ltd., a subsidiary of VBI Vaccines Inc. (Nasdaq: VBIV), has the facilities and expertise that enable development of therapeutic proteins starting with a selected clone, through production, purification, and analytical testing. For your phase I and II clinical trials, SciVac Ltd. offers manufacturing services under cGMP conditions.

keywords:N/A

N/A

Total Funding

59

Number of Employees

$9.1M

Revenue (est)

-23%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.1M59-23%N/A
#2
$9.2M60-9%N/A
#3
N/A63-3%N/A
#4
$10.1M65-2%N/A
#5
$18.1M727%N/A